JALMARTI
DEAD

Serial Number

97307174

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 11, 2022

Add to watchlist:

No watchlists yet
View on USPTO

JALMARTI Trademark

Serial Number: 97307174

JALMARTI is a trademark filed by NOVARTIS AG on March 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 11, 2022

Registration Date

Not Registered

Published for Opposition

December 20, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Feb 20, 2025 MAB5
ABANDONMENT - AFTER PUBLICATION
Feb 20, 2025 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Feb 19, 2025 EXAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 5, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 4, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 5, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 5, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 12, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 12, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 4, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 4, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 4, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 30, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2022 CNSA
ASSIGNED TO EXAMINER
Nov 7, 2022 DOCK
PETITION TO DIRECTOR - MAKE SPECIAL - DENIED
Apr 20, 2022 PMSD
ASSIGNED TO PETITION STAFF
Apr 19, 2022 APET
TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Apr 12, 2022 TPMS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2022 NWOS
NEW APPLICATION ENTERED
Mar 15, 2022 NWAP